Gene expression involves multiple regulated steps leading from gene to acti
ve protein. Many of these steps involve some aspect of RNA processing. Dise
ases caused by mutations that directly affect RNA processing are relatively
rare compared with mutations that disrupt protein function. The vast major
ity of diseases of RNA processing result from loss of function of a single
gene due to mutations in cis-acting elements required for pre-messenger RNA
(mRNA) splicing. However, a few diseases are caused by alterations in the
trans-acting factors required for RNA processing and in the vast majority o
f cases it is the pre-mRNA splicing machinery that is affected. Clearly, al
terations that disrupt splicing of pre-mRNAs from large numbers of genes wo
uld be lethal at the cellular level. A common theme among these diseases is
that only subsets of genes are affected. This is consistent with an emergi
ng view that different subsets of exons require different sets of cis-actin
g elements and trans-acting factors.